A post-treatment blood test could inform future cancer therapy decisions
In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with lung cancer years ...
Mar 17, 2025
0
62